[Effects of penfluridol, a psychotropic agent, on operant behavior of rats]. 1975

H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro

Effects of penfluridol, a diphenylbutylpiperidine type psychotropic agent, on operant behavior were investigated and compared with those of chlorpromazine and haloperidol in rats trained on the following 5 schedules. Fixed ratio (FR 30) of food reinforcement and differential water reinforcement of low rate (DRL 20 sec) schedules were used for positively reinforced behaviors. Continuous (Sidman-type) and discriminated avoidance schedules were used for negatively reinforced behaviors. Conditioned suppression of response (CER) under FR 30 developed by stimulus presentation with electric shock was also applied. When 1 mg/kg of penfluridol was given orally, no change was observed in respondings of all the performances. At higher doses (2 approximately 8 mg/kg, p.o.), the respondings were inhibited in proportion to the dosage except in DRL performance, in which only correct response rate decreased at 8 mg/kg. These inhibitory effects were observed more apparently in the negatively reinforced behaviors than in the positively reinforced ones. Furthermore, a clear dose-effect relationship was obtained in the former. CER was not all attenuated by 2 approximately 8 mg/kg of penfluridol, thus a diazepam-like effect was not confirmed. These behavioral effects suggested that penfluridol has neuroleptic properties similar to those observed with chlorpromazine or haloperidol. However, in general, the inhibitory effects reached the maximum level approximately at 16 hr and lasted for 2 approximately 3 days after oral administration of the drug. Intensity of the effect of penfluridol was estimated to be about 1/8 approximately 1/10 that of haloperidol, according to the results obtained in the avoidance performances.

UI MeSH Term Description Entries
D008297 Male Males
D010395 Penfluridol One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS. R-16341,Semap,R 16341,R16341
D010880 Piperidines A family of hexahydropyridines.
D012055 Reinforcement Schedule A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent. Reinforcement Schedules,Schedule, Reinforcement,Schedules, Reinforcement
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
August 1961, The Journal of pharmacology and experimental therapeutics,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
January 1976, Proceedings of the Western Pharmacology Society,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
January 1981, Bioelectromagnetics,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
November 1978, The Journal of pharmacology and experimental therapeutics,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
January 1989, Psychopharmacology,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
January 1982, Peptides,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
August 1963, Archives internationales de pharmacodynamie et de therapie,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
January 1982, Neurobehavioral toxicology and teratology,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
December 1985, Psychological reports,
H Kuribara, and K Okuizumi, and M Shirota, and S Tadokoro
January 1969, Acta physiologica latino americana,
Copied contents to your clipboard!